Why is ABBV stock moving?
AbbVie Inc. · end-of-day data as of Oct 16, 2026
AbbVie Inc.
$285.42+10.7%
Buy · 30 analystsPT $281.54 -1.4%
The move, split
AbbVie Inc. (ABBV) rose 0.7% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move is specific to ABBV.
Market (SPY)-1.1%
Healthcare sector+0.4%
ABBV specific+1.5%
4 stories on the day (30-day average 3.8).
- SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026
- SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026
- AbbVie Inc. $ABBV Shares Sold by Banque Pictet & Cie SA
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Context
- News
- Volume1.2x
- Off 52w high0.0%
- Sector▲ +16.0%
- Earnings in14d
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.